Cerebrolysin vs Selank-Amidate

Overview

Cerebrolysin is primarily a pain management peptide, while Selank-Amidate is used for cognitive enhancement.

This page compares Cerebrolysin and Selank-Amidate across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

Key differences

Primary use. Cerebrolysin is categorised under Pain Management, while Selank-Amidate falls under Cognitive Enhancement. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. Cerebrolysin: not FDA-approved; treated as a research compound. Selank-Amidate: not FDA-approved; treated as a research compound.

Dosing. Cerebrolysin is typically dosed at 5-10 ml (multiple weekly). Selank-Amidate is typically dosed at 250-500 mcg (daily).

Can you stack them?

Some protocols combine peptides, but stacking Cerebrolysin and Selank-Amidate has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Cerebrolysin and Selank-Amidate?

Cerebrolysin is primarily a pain management peptide, while Selank-Amidate is used for cognitive enhancement. Cerebrolysin is not FDA-approved; generally classified as a research compound, whereas Selank-Amidate is not FDA-approved; generally classified as a research compound.

What is Cerebrolysin used for?

Neuropathic pain support.

What is Selank-Amidate used for?

Extended release Selank.

Can you take Cerebrolysin and Selank-Amidate together?

Some users combine peptides within a single protocol, but stacking Cerebrolysin and Selank-Amidate has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.

Is Cerebrolysin or Selank-Amidate FDA-approved?

Cerebrolysin is not FDA-approved; generally classified as a research compound. Selank-Amidate is not FDA-approved; generally classified as a research compound.